Basic Study
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

World J Clin Oncol
7(6):425-432.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.425
Abstract (1245)
|
Core Tip (1068)
|
Full Article (HTML) (3658)
|
Figures (1-2) (359)
|
Tables (1-2) (322)
|
Full Article (PDF)-2061K (448)
|
Audio-594K (61)
|
Peer-Review Report-120K (241)
|
Answering Reviewers-141K (276)
|
Received: 06/20/2016
|
Revised: 08/12/2016
|
Accepted: 10/27/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (7)
|
Total Visits (13036)
|
Similar Articles (98)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Clin Oncol
7(6):433-440.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.433
Abstract (1248)
|
Core Tip (1195)
|
Full Article (HTML) (3971)
|
Figures (1-3) (659)
|
Tables (1-2) (381)
|
Full Article (PDF)-1143K (488)
|
Audio-1781K (20)
|
Peer-Review Report-120K (254)
|
Answering Reviewers-566K (335)
|
Received: 08/03/2016
|
Revised: 09/10/2016
|
Accepted: 10/18/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (15874)
|
Similar Articles (979)
|
Timeline of Article Publication (0)
|
Authors Evaluation (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open